Skip to content
Govbase
Govbase
Congress·In Committee·S. 4692

Homeopathic Drug Product Safety, Quality, and Transparency Act

Sen. Tuberville Introduces Bill to Create New Safety Standards for Homeopathic Medicines

This bill was introduced in the Senate and is currently being reviewed by the Committee on Health, Education, Labor, and Pensions. It is in the early stages of the lawmaking process and has not yet been scheduled for a vote. The bill is still active as it waits for the committee to decide on its next steps.

Legislative Progress

Senate
House
President
Law
Unlikely to pass

While the bill has support from some conservative leaders, it currently lacks the broad bipartisan backing needed to pass through a divided Congress.

Key Points

Healthcare

Impact Analysis

Personal Impact

Life & Work

Small homeopathic manufacturers would benefit significantly from this bill. By exempting homeopathic products from the standard FDA drug approval process and creating tailored manufacturing and labeling rules, the bill removes major regulatory barriers that are costly and difficult for small businesses to navigate. The advisory committee is also required to include representatives of both large and small domestic manufacturers, giving smaller firms a voice in future rulemaking.

Homeopathic drug products shall not be subject to section 505 and shall not be required to be the subject of an approved application under such section.
3
2
2
5
+3
ImpactCertaintyScopeDurationSentiment

Disabilities

Milestones

2 milestones2 actions
Jun 4, 2026Senate

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.

Jun 4, 2026

Introduced in Senate

The bill was officially filed and given a number. It now enters the legislative queue.

Votes

No votes have been recorded for this legislation yet.

Source Information

Document Type

Congressional Bill

Official Title

Homeopathic Drug Product Safety, Quality, and Transparency Act

Bill NumberS 4692
Congress119th Congress
ChamberSenate
Latest ActionRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsor

Cosponsors

(1)
R: 1

Analysis generated by AI. Always verify with official sources.